Hoge Stephen
Hoge Stephen, PRES, reported a transaction classified as exercise at Moderna, Inc. involving 76452.000000 shares for an estimated $0.00. Reported holdings after the transaction were 152905.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Oct 15, 2026
- Filing date
- Oct 16, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
MRNA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001682852-26-000187 Stock Option (Right to Buy)
- Transaction date
- Oct 15, 2026 Filed Oct 16, 2026, 08:09 PM · 1d delay
- Shares
- 76,452 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 152,905 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
President
- F1
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $213.03 to $213.91. Full information regarding the number of shares sol…
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $214.05 to $214.37. Full information regarding the number of shares sol…
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $220.60 to $221.35. Full information regarding the number of shares sol…
- F5
These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these…
- F6
This option is fully vested and exercisable.
0 other transactions
0 recent txs